143 related articles for article (PubMed ID: 26299428)
21. Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells.
Jan HJ; Lee CC; Lin YM; Lai JH; Wei HW; Lee HM
Cancer Lett; 2009 May; 277(2):141-8. PubMed ID: 19168281
[TBL] [Abstract][Full Text] [Related]
22. Higher expression of peroxisome proliferator-activated receptor γ or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasion.
Yang DR; Lin SJ; Ding XF; Miyamoto H; Messing E; Li LQ; Wang N; Chang C
Urology; 2013 May; 81(5):1109.e1-6. PubMed ID: 23522297
[TBL] [Abstract][Full Text] [Related]
23. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
[TBL] [Abstract][Full Text] [Related]
24. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
Cellai I; Benvenuti S; Luciani P; Galli A; Ceni E; Simi L; Baglioni S; Muratori M; Ottanelli B; Serio M; Thiele CJ; Peri A
Br J Cancer; 2006 Oct; 95(7):879-88. PubMed ID: 16969347
[TBL] [Abstract][Full Text] [Related]
25. Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK.
Kim KH; Cho YS; Park JM; Yoon SO; Kim KW; Chung AS
FEBS Lett; 2007 Jul; 581(17):3303-10. PubMed ID: 17597617
[TBL] [Abstract][Full Text] [Related]
26. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
Cao LQ; Chen XL; Wang Q; Huang XH; Zhen MC; Zhang LJ; Li W; Bi J
Acta Pharmacol Sin; 2007 Jun; 28(6):879-87. PubMed ID: 17506947
[TBL] [Abstract][Full Text] [Related]
28. Morin Exerts Anti-Arthritic Effects by Attenuating Synovial Angiogenesis via Activation of Peroxisome Proliferator Activated Receptor-γ.
Yue M; Zeng N; Xia Y; Wei Z; Dai Y
Mol Nutr Food Res; 2018 Nov; 62(21):e1800202. PubMed ID: 30160015
[TBL] [Abstract][Full Text] [Related]
29. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
[TBL] [Abstract][Full Text] [Related]
30. Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway.
Jin JQ; Han JS; Ha J; Baek HS; Lim DJ
Endocrinol Metab (Seoul); 2021 Oct; 36(5):1095-1110. PubMed ID: 34645125
[TBL] [Abstract][Full Text] [Related]
31. PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.
Zhang W; Wu N; Li Z; Wang L; Jin J; Zha XL
Cancer Biol Ther; 2006 Aug; 5(8):1008-14. PubMed ID: 16775433
[TBL] [Abstract][Full Text] [Related]
32. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Shen B; Chu ES; Zhao G; Man K; Wu CW; Cheng JT; Li G; Nie Y; Lo CM; Teoh N; Farrell GC; Sung JJ; Yu J
Br J Cancer; 2012 Apr; 106(9):1486-94. PubMed ID: 22472882
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
34. Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.
Han F; Zhu HG
J Surg Res; 2010 Mar; 159(1):443-50. PubMed ID: 20031158
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression.
Higuchi T; Takeuchi A; Munesue S; Yamamoto N; Hayashi K; Kimura H; Miwa S; Inatani H; Shimozaki S; Kato T; Aoki Y; Abe K; Taniguchi Y; Aiba H; Murakami H; Harashima A; Yamamoto Y; Tsuchiya H
Cancer Med; 2018 May; 7(5):1944-1954. PubMed ID: 29573200
[TBL] [Abstract][Full Text] [Related]
36. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
[TBL] [Abstract][Full Text] [Related]
37. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH
Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731
[TBL] [Abstract][Full Text] [Related]
38. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system.
Sawai H; Liu J; Reber HA; Hines OJ; Eibl G
Mol Cancer Res; 2006 Mar; 4(3):159-67. PubMed ID: 16547153
[TBL] [Abstract][Full Text] [Related]
39. Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.
Liu J; Zhang Y; Yu C; Zhang P; Gu S; Wang G; Xiao H; Li S
Drug Dev Res; 2021 Apr; 82(2):278-286. PubMed ID: 33112006
[TBL] [Abstract][Full Text] [Related]
40. RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
Papi A; Rocchi P; Ferreri AM; Orlandi M
Cancer Lett; 2010 Nov; 297(1):65-74. PubMed ID: 20510503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
